The 2026 kratom map — where each state stands

Tap any state for its statute, dates, and sources.

U.S. kratom status · October 2026

All 50 states and D.C.: 10 ban kratom, 24 states and D.C. regulate it, 15 have no state law

U.S. kratom legal status by state, October 2026 AK ME WI VT NH WA ID MT ND MN IL MI NY MA RI OR NV WY SD IA IN OH PA NJ CT CA UT CO NE MO KY WV VA MD DE AZ NM KS AR TN NC DC OK LA MS AL SC HI TX GA FL Tennessee — ban in effect July 1, 2026 · home state
  • Fully banned · 10 states In most of these states, possession, sale, and manufacture are criminal offenses.
  • Legal, with state rules · 24 states + D.C. Age limits, labeling, licensing, or 7-OH limits, depending on the state.
  • Reversed a ban · Rhode Island Banned 2017 to 2026; legal for adults 21 and older under state rules since April 1, 2026.
  • No statewide kratom law · 15 states Legal at the state level; federal law and some city or county rules still apply.
  • Ban bill passed one chamber · Michigan Still alive in the legislature in October 2026; not law.

Status as of October 16, 2026, checked against each state’s legislature or agency site and the Legislative Analysis and Public Policy Association’s January 2026 survey of state kratom laws. Every state and D.C. is listed below with its law and source. Enforcement varies, and a city or county can be stricter than its state.

Fully banned

Where kratom is illegal

10 states

As of October 2026, ten U.S. states treat kratom itself as a controlled or prohibited substance. Four joined in 2026: Connecticut (Schedule I regulations approved in February), Kansas (mitragynine added to Schedule I by a law signed April 27), Tennessee (July 1), and Massachusetts (a temporary emergency placement in August). In most of these states, possession, sale, and manufacture are criminal offenses; the specific penalties and statutory mechanisms vary by state.

Home state · ban in effect

Tennessee

Effective Jul 1, 2026

HB1649/SB1656, called “Matthew Davenport’s Law,” passed both chambers on April 16, 2026 with a Senate vote of 23-3. Gov. Bill Lee signed it into law on May 7, 2026 (Public Chapter 950); it took effect July 1, 2026. Penalties are Class A misdemeanor for knowing possession, Class C felony for manufacture, delivery, or sale, and Class B felony for sale to a minor. The introduced version (HB1647/SB1655) carried a harsher Class D/Class B/Class A felony structure; the passed substitute reduced possession from felony to misdemeanor before clearing the legislature. See our Tennessee kratom ban law article.

Massachusetts

Aug 2026 · temporary

Massachusetts is the most recent addition to the banned-state list. The state Department of Public Health placed kratom in Schedule 1 under Massachusetts law by an emergency regulation published August 13, 2026 (105 CMR 726.000, “Temporary placement of kratom in Schedule 1”). Because it is an emergency regulation, this status can change.

Kansas

Banned 2026

Kansas banned kratom through two 2026 laws. House Bill 2365, approved April 10, 2026, placed 7-hydroxymitragynine in Schedule I. Senate Bill 430, approved April 27, 2026, added mitragynine, the main alkaloid in kratom leaf, to the same schedule. Both took effect on publication in the Kansas statute book, so plain kratom is now a Schedule I substance in Kansas.

Connecticut

Banned 2026

Connecticut joined the banned-state list in 2026, when its Legislative Regulation Review Committee approved regulations placing kratom and its derivatives, including 7-OH, in Schedule I. Schedule I placement makes possession, sale, and manufacture of kratom and its alkaloid derivatives illegal. Retailers were given a compliance window to clear their inventory.

Louisiana

Effective Aug 2025

Louisiana enacted a full kratom ban in August 2025 via Senate Bill 154 (Act 41). The statute criminalizes possession, sale, and manufacture of kratom and its alkaloid derivatives. Post-effective-date enforcement has included retailer inspections and product-seizure authority; penalties escalate for repeat violations under the state controlled-substance statute.

Alabama

Schedule I since 2016

Alabama was the first state to classify mitragynine and 7-hydroxymitragynine as Schedule I controlled substances, under Alabama Code § 20-2-23, in place since 2016. Knowing possession of any quantity is a Class C felony; manufacture, delivery, or sale rises to a Class B felony. On March 25, 2026, the Alabama Attorney General issued a statewide cease-and-desist wave targeting branded kratom and 7-OH products. See our companion article on Alabama kratom law in 2026.

Arkansas

Schedule I since 2016

Arkansas followed Alabama’s lead in 2016, adding mitragynine and 7-hydroxymitragynine to the state’s Schedule I list. Penalties follow Arkansas’s general controlled-substance statute: possession is a felony, and trafficking carries multi-year prison exposure depending on quantity and prior record. Arkansas has not revisited its classification despite lobbying by kratom consumer groups.

Indiana

Synthetic-drug statute

Indiana classifies kratom alkaloids under its synthetic drug statute (IC 35-31.5-2-321) rather than a controlled-substance list, criminalizing possession, sale, and manufacture with penalty tiers comparable to controlled-substance offenses. The practical effect for consumers is the same: possession is a criminal offense and commercial retail is prohibited.

Vermont

Regulated drug since 2016

Since January 1, 2016, Vermont has listed mitragynine and 7-hydroxymitragynine in its Regulated Drug Rule (12-5 Vt. Code R. § 23:7.0), which makes a listed drug illegal unless a licensed professional prescribes and dispenses it. The rule covers both alkaloids, so it reaches whole-leaf kratom and concentrated 7-OH products alike.

Wisconsin

Schedule I

Wisconsin treats kratom alkaloids as Schedule I controlled substances under Wisconsin Statute 961.14. Possession and distribution are criminal offenses. Wisconsin has not adopted a KCPA-style regulatory alternative despite proposals to reclassify or exempt specific product categories.

Reversed a ban

Rhode Island — the first reversal

1 state

Rhode Island had banned kratom since 2017 under a Department of Health action that placed mitragynine and 7-hydroxymitragynine on the state’s prohibited-substance list. That ban was reversed effective April 1, 2026, the first time a U.S. state has reversed a kratom ban.

Rhode Island

Reversed Apr 1, 2026

The reversal came under the Rhode Island Kratom Act (R.I. Gen. Laws Ch. 21-28.12), which follows the Kratom Consumer Protection Act model: kratom is legal for adults aged 21 and older, subject to labeling, third-party laboratory testing, limits on 7-OH concentration, and a prohibition on synthetic alkaloid additives. Advocates argued that a full ban pushed Rhode Island consumers toward unregulated out-of-state and online vendors, increased exposure to adulterated and mislabeled products, and did not reduce kratom dependence. As of October 2026, no other state has reversed a kratom ban.

Legal, with state rules

States that regulate kratom sales

24 states + D.C.

In 24 states and the District of Columbia, kratom leaf is legal for adults, but a state law or rule controls how it is sold. Most of these states use some version of the Kratom Consumer Protection Act (KCPA), a model law. Others set only an age limit, or list concentrated 7-OH as a controlled substance while leaving leaf kratom legal. Provisions vary by state and commonly include:

Age

Minimum purchase age 21 in most regulating states and 18 in the rest; retailers may not sell to anyone younger.

Labeling

Full product labeling Mitragynine and 7-hydroxymitragynine content, serving size, batch/lot ID, expiration date, and a visible 21-plus warning. Some states also require habit-forming and FDA-non-evaluation statements.

Potency

7-OH concentration cap Most KCPA states cap 7-hydroxymitragynine at 2 percent of total alkaloid content; some add absolute-milligram caps.

Purity

No synthetic alkaloids Manufacturers cannot chemically modify kratom alkaloids or spike products with synthesized mitragynine or 7-OH isolates.

Testing

Lab testing (some states) Some states require testing for alkaloid content and contaminants such as heavy metals before a product can be sold.

Registration

Product registration Utah requires each kratom product to be registered with the state before it can be sold.

Every regulating state, with its law and what it requires:

  • ArizonaSince 2019A.R.S. §§ 36-795 to 36-795.03Age 18; labeling; 7-OH capped at 2% of alkaloids; synthetic alkaloids banned.
  • ColoradoSince 2022C.R.S. § 44-1-105; S.B. 25-072Age 21; labeling. A 2025 law added a 7-OH limit and rules on synthesized alkaloids and candy-like products.
  • DelawareSince Sept 202685 Del. Laws ch. 478 (H.S. 1 for H.B. 332)Age 21; selling to anyone younger is a class B misdemeanor. A report on testing and retailer licensing is due January 1, 2027.
  • FloridaSince 2023Fla. Stat. § 500.92; emergency rule 2ER26-2Age 21. 7-OH above a set concentration is in Schedule I under an Attorney General emergency rule (August 2026).
  • GeorgiaSince 2019O.C.G.A. §§ 16-13-120 to -122Age 21 since January 1, 2025; labeling and product limits. Details in our Georgia kratom law article.
  • IllinoisSince 2015720 ILCS 642Age 18 only; no labeling rules.
  • KentuckySince 2024KRS §§ 217.2201 to .2209; 902 KAR 55:015Regulated sales today. 7-OH above 400 parts per million became Schedule I on March 12, 2026, and a 2026 act (H.B. 757, Acts ch. 161) ends kratom sales by processors and retailers on July 1, 2027. H.B. 869 moved that date from January 1, 2027.
  • MarylandSince 2024Health–Gen. §§ 21-2E-01 to -04 (2024 ch. 748); 2026 ch. 354Age 21; labeling; 7-OH capped at 2% of alkaloids; synthetic alkaloids banned. Since July 1, 2026 the Alcohol, Tobacco, and Cannabis Commission can cite retailers and seize noncompliant kratom products.
  • MinnesotaSince 2018Minn. Stat. § 152.027, subd. 7Age 21 since August 1, 2026 (Laws 2026, ch. 63); no labeling rules.
  • MississippiSince 2025Miss. Code §§ 75-103-1 to -7Retailer registration and a kratom excise tax, in effect July 1, 2025.
  • NebraskaSince 2025Neb. Rev. Stat. §§ 71-3801 to -3816Age 21; 7-OH capped at 2% of alkaloids; synthetic alkaloids excluded. A 2026 law (LB 901) added adulteration rules and a kratom excise tax.
  • NevadaSince 2019NRS 597.998Age 18; labeling and product limits.
  • New YorkSince Dec 2025Pub. Health Law § 1399-mmm (2025 ch. 690)Age 21 since December 19, 2025. A labeling law (Gen. Bus. Law § 398-g) takes effect in December 2026.
  • North DakotaSince Sept 2026H.B. 1628 (2026 special session)Age 21, licensing, and labeling. The enrolled bill puts 7-OH above 0.05 percent (or more than 1 milligram in an extract, pill, or other processed product) and synthetic and semi-synthetic derivatives such as MGM-15 in Schedule I. No kratom sales are lawful until the Attorney General adopts the licensing rules.
  • OhioSince Dec 2025Ohio Adm. Code 4729:9-1-01.1A Board of Pharmacy rule lists 7-OH and related compounds in Schedule I. The rule excludes natural kratom leaf and ground leaf.
  • OklahomaSince 202163 O.S. §§ 1-1432.1 to -1432.5Age 18; labeling and product limits.
  • OregonSince 2023ORS 475.394 to 475.404Age 21; processor registration; no labeling rules.
  • South CarolinaSince 2025S.C. Code §§ 44-53-2010 to -2040 (Act 35 of 2025)Age 21; 7-OH content on the label; synthetic alkaloids banned. A 2026 ban bill (H. 4641) passed the House but died in a Senate committee.
  • South DakotaSince 2021SDCL § 34-20B-115Age 21; labeling; amended July 1, 2025.
  • TexasSince 2023Tex. Health & Safety Code ch. 445 (formerly ch. 444)Age 18; labeling and product limits.
  • UtahSince 2019Utah Code §§ 4-45-101 to -108; S.B. 45 (2026)Product registration. Since May 6, 2026: age 21, sales only through licensed tobacco specialty retailers, and 7-OH and mitragynine pseudoindoxyl in Schedule I, with pure leaf exempted.
  • VirginiaSince 2023Va. Code § 59.1-200(77)Age 21. A 2026 law (H.B. 360, ch. 595) tightened product rules.
  • West VirginiaSince 2023W. Va. Code ch. 19, art. 12FAge 21; business registration. A 2026 law (S.B. 985) added online age checks.
  • WyomingSince July 2026S.F. 56 (2026 ch. 68)Age 21; 7-OH capped at 2% of alkaloids; synthetic alkaloids excluded.
  • District of ColumbiaSince 201622-B DCMR § 1201The Schedule I rule lists “(Kratom) 7-hydroxymitragynine” among unclassified novel psychoactive substances; kratom leaf and mitragynine are not listed. The LAPPA state-law survey describes D.C.’s status as unclear.

Penalties under these laws fall on retailers and processors, and in several states a violation is a misdemeanor. The counts on this page start from the Legislative Analysis and Public Policy Association’s January 2026 survey of state kratom laws and add the laws enacted since, each checked against the state’s own legislature or agency site.

Dependent on kratom or 7-OH?

Our clinics in Chattanooga, Cleveland, and Soddy-Daisy, Tennessee, and Ringgold, Georgia, treat kratom and 7-OH dependence with buprenorphine-based MAT, and same-week appointments are available. Call or request a callback and we will check your insurance before your first visit.

No state law

States with no statewide kratom law

15 states

These states have no state law that regulates or bans kratom itself, so kratom is legal to sell and possess at the state level. Federal law still applies everywhere: since August 26, 2026, mitragynine pseudoindoxyl, MGM-15, and MGM-16 have been temporarily in federal Schedule I. Some cities and counties also set their own rules.

  • Alaska
  • California
  • Hawaii
  • Idaho
  • Iowa
  • Maine
  • Michigan
  • Missouri
  • Montana
  • New Hampshire
  • New Jersey
  • New Mexico
  • North Carolina
  • Pennsylvania
  • Washington
  • CaliforniaNo kratom statute, but the Department of Public Health treats foods containing kratom or 7-OH as adulterated and says selling them is illegal under state food law.
  • New JerseyThe three synthetic compounds became controlled in New Jersey in September 2026, following the federal order. The Attorney General says natural kratom is not illegal.
  • HawaiiThe state Narcotics Enforcement Division posted a 2026 emergency scheduling notice for kratom-related synthetic opioids. Its 2025 kratom consumer protection bills did not pass.
  • AlaskaNo state bill has advanced. The Anchorage Assembly began considering a city ban on kratom products in October 2026.
  • IdahoA kratom consumer protection bill (S. 1418) failed in the Senate, 15–20, on March 30, 2026.
  • Michigan & PennsylvaniaBills are still alive in both; see pending bills below.
Pending

Bills that could change the map

Checked October 16, 2026

Most legislatures finished their 2026 sessions by June, so most 2026 kratom bills are no longer alive. These two were still moving when we last checked:

Michigan

H.B. 5537 · ban · passed the House

House Bill 5537 would make producing and selling kratom a crime. It passed the House 56–48 on March 18, 2026 and has been in the Senate Committee on Government Operations since March 24. Michigan’s legislature meets year-round, so the bill stays alive until the current session ends.

Pennsylvania

H.B. 2657 · regulation · passed the House

House Bill 2657, the Kratom Standards, Labeling, and Consumer Protection Act, would regulate kratom rather than ban it. It passed the House and went to the Senate Health and Human Services Committee on October 13, 2026.

Did not pass in 2026

Sessions over

Ban bills in South Carolina (H. 4641, which passed the House), Georgia (HB 968), and Delaware (S.B. 262) ended without becoming law, as did Washington’s regulation bill (SB 6287) and 95 percent excise tax bill (SB 6196). Delaware passed an age-21 law instead, listed above.

2026

What changed in 2026

State actions, in date order
  • ConnecticutFeb 24Regulations placing kratom and 7-OH in Schedule I approved by the Legislative Regulation Review Committee.
  • WyomingMar 6S.F. 56 signed: age 21 and a 2% 7-OH cap, effective July 1.
  • KentuckyMar 127-OH above 400 parts per million placed in Schedule I; a sales ban followed in H.B. 757, effective July 1, 2027.
  • Rhode IslandApr 1Ban reversed; the Rhode Island Kratom Act took effect.
  • KansasApr 10 & 27H.B. 2365 (7-OH) and S.B. 430 (mitragynine) approved, placing kratom in Schedule I.
  • MinnesotaMay 5Purchase age raised to 21, effective August 1.
  • UtahMay 6S.B. 45 took effect: age 21, licensed retailers only, 7-OH and mitragynine pseudoindoxyl in Schedule I.
  • TennesseeMay 7HB1649/SB1656 signed (Public Chapter 950); the ban took effect July 1.
  • MarylandJul 1Chapter 354 took effect, giving the Alcohol, Tobacco, and Cannabis Commission enforcement and seizure power.
  • MassachusettsAug 13Emergency regulation temporarily placing kratom in Schedule 1 published.
  • North DakotaSept 4H.B. 1628 signed after a special session: licensing, age 21, and Schedule I for 7-OH above 0.05 percent and for synthetic and semi-synthetic derivatives.
  • DelawareSept 8H.S. 1 for H.B. 332 signed: no sales to anyone under 21.

Kratom legislation can shift during a session. This is factual reporting on U.S. kratom law as of October 2026, not legal advice. If you have a specific legal question about your state or a cross-border scenario, consult an attorney licensed in the relevant jurisdiction. Whatever a state decides, buprenorphine-based treatment for kratom or 7-OH dependence is legal in every U.S. state — the sections below cover what any state’s status means for treatment access.

Federal status — kratom unscheduled, 7-OH scheduling pending

At the federal level, kratom itself remains unscheduled under the Controlled Substances Act. The DEA did not follow through on a proposed temporary scheduling of mitragynine and 7-hydroxymitragynine that was floated and then withdrawn in 2016. The DEA’s Diversion Control Division keeps a kratom fact sheet in its Drugs and Chemicals of Concern series; the October 2025 edition says kratom “is not a controlled substance or listed chemical under the Controlled Substances Act.”

On July 29, 2025, the FDA formally recommended to the DEA that concentrated 7-hydroxymitragynine products be scheduled as Schedule I under the Controlled Substances Act. The recommendation was narrow: it targeted concentrated 7-OH products specifically — tablets, gummies, drink mixes, and shots with elevated 7-OH concentrations — rather than natural whole-leaf kratom. Two weeks earlier, on July 15, 2025, the FDA had announced warning letters to seven companies marketing 7-OH products. On July 6, 2026 the DEA published a notice of intent to temporarily place 7-OH above a specified threshold in Schedule I, and on October 14, 2026 it replaced that notice with a new one that covers 7-OH and mitragynine pseudoindoxyl above a new threshold. As of October 2026 no temporary scheduling order has been issued, so 7-OH is still not federally scheduled. Permanent scheduling would still require standard rulemaking with a public-comment period.

If concentrated 7-OH is federally scheduled, it becomes illegal to manufacture, sell, or possess nationwide — regardless of any individual state’s position. Our companion explainer on 7-OH versus whole-leaf kratom covers the pharmacology and regulatory distinction in more depth, and our Is 7-OH banned yet? 2026 status tracker follows the federal scheduling timeline.

What any state’s status means for treatment access

If you or someone you care about is dependent on kratom or 7-OH, the legal status of kratom in your state does not affect whether treatment is available, effective, or covered by insurance. It only affects supply.

In a banned state?

Buprenorphine-based treatment for kratom or 7-OH dependence is legal in every U.S. state, and you do not have to live in the state where you are treated. Your home state’s kratom law doesn’t change whether you can start treatment.

Buprenorphine-based MAT works for kratom dependence regardless of state law

Kratom’s primary active alkaloids, mitragynine and 7-hydroxymitragynine, act on the same mu-opioid receptors that fentanyl, heroin, and prescription opioids act on. Although kratom is not itself a classical opioid, the receptor activity means that the same medication-assisted treatment protocol used for opioid use disorder is clinically effective for kratom dependence. Buprenorphine, the active medication in Suboxone, Sublocade, and Brixadi, is a partial opioid agonist that relieves kratom withdrawal, suppresses craving, and provides a stable transition off kratom products over weeks rather than days. These medications are legal and available in every U.S. state because they are FDA-approved with a federal indication for opioid use disorder.

Cross-state outpatient MAT if your home state has banned kratom

If you live in a state where kratom is banned and you are dependent, you can get outpatient MAT at a clinic in a neighboring state. Buprenorphine prescribing is governed by federal law and does not require residency in the prescribing state. Whether your insurance covers a clinic in another state depends on your carrier, so check your coverage before your first visit. In our own geography, Alabama residents from Jackson County can come to Restoration Recovery’s Chattanooga clinic for outpatient MAT; Chattanooga is our nearest clinic to them.

42 CFR Part 2 confidentiality regardless of state

Federal confidentiality protections under 42 CFR Part 2 apply to addiction treatment records regardless of the state in which care is delivered. This is a stricter standard than HIPAA and is explicitly designed to prevent disclosure of substance-use-disorder treatment to law enforcement, employers, or insurers without patient consent. Seeking treatment for kratom or 7-OH dependence does not generate a criminal record, a disclosure to kratom-law enforcement, or a public record that could affect employment, housing, or custody.

Common questions about kratom law by state

Which U.S. states have fully banned kratom as of October 2026?

Ten U.S. states fully ban kratom as of October 2026: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Massachusetts, Tennessee, Vermont, and Wisconsin. In most of these states, possession, sale, and manufacture are criminal offenses, with penalties ranging from misdemeanor to felony. Four joined in 2026: Connecticut placed kratom and 7-OH in Schedule I by regulations approved in February, Kansas added mitragynine and 7-OH to Schedule I in laws signed in April, Tennessee’s ban took effect July 1, 2026 (HB1649/SB1656, signed May 7, 2026, Public Chapter 950), and Massachusetts placed kratom in Schedule 1 by a temporary emergency regulation in August 2026.

Is Rhode Island the first state to reverse a kratom ban?

Yes. Rhode Island had banned kratom since 2017 but reversed the ban effective April 1, 2026, making it the first U.S. state to reverse a kratom ban. The new regulatory framework allows kratom sales to adults aged 21 and older with labeling, testing, and product-safety requirements modeled on the Kratom Consumer Protection Act used in other regulated states. The reversal was driven by advocacy arguments that a ban pushed consumers to unregulated sources and created patchwork enforcement problems without reducing dependence.

What is the Kratom Consumer Protection Act (KCPA)?

The Kratom Consumer Protection Act is a model law that many states have adopted in some form. As of October 2026, 24 states and the District of Columbia regulate kratom sales, most with a KCPA-style law and the rest with an age limit or a 7-OH rule alone. Common provisions include a minimum purchase age (21 in most of these states, 18 in some), product labeling with mitragynine and 7-hydroxymitragynine content, caps on 7-OH concentration (commonly 2 percent of total alkaloids), a ban on synthetic alkaloids, and penalties for retailers who sell to minors or mislabel products. Some states also require lab testing, product registration, or retailer licensing.

Which states have pending kratom ban bills in 2026?

As of October 16, 2026, the main ban bill still alive is Michigan’s House Bill 5537, which passed the House on March 18, 2026 and is in a Senate committee. Pennsylvania’s House passed a bill to regulate kratom (HB 2657) in October 2026. Most other 2026 bills ended with their sessions, including ban bills in South Carolina (H. 4641), Georgia (HB 968), and Delaware (SB 262). Kansas and Tennessee enacted bans in 2026, and Delaware, Wyoming, and North Dakota passed laws regulating kratom.

If I live in a banned-kratom state and am dependent, can I get treatment elsewhere?

Yes. Buprenorphine-based medication-assisted treatment (Suboxone, Sublocade, Brixadi) is legal in every U.S. state because it uses FDA-approved medications with a federal indication for opioid use disorder. Someone who lives in a state that bans kratom can get outpatient MAT at a clinic in a neighboring state. Whether your insurance covers a clinic in another state depends on your carrier, so check your coverage before your first visit. Restoration Recovery’s clinics are in Chattanooga, Cleveland, and Soddy-Daisy, Tennessee, and Ringgold, Georgia, and patients from nearby Alabama counties can come to our Chattanooga clinic.

Where to check current state status

Kratom legislation can shift during a legislative session. For the most current state-level bill status, LegiScan and BillTrack50 publish up-to-date committee actions, floor votes, and signing actions for every state. State legislature websites (typically [state].gov or legis.[state].gov) publish full bill text and voting records. The Legislative Analysis and Public Policy Association publishes a nonpartisan summary of state kratom laws with statutory citations, and the American Kratom Association, an industry advocacy group, also tracks active bills. For the federal picture, DEA and FDA press releases and notices in the Federal Register are authoritative. We update this article and our Tennessee, Georgia, and Alabama state pages when a bill passes, fails, or takes effect.

This article is published for patient information only. It is not legal advice. If you have a specific legal question about your state or a potential cross-border scenario, consult an attorney licensed in the relevant jurisdiction.

If you are ready to stop using kratom or 7-OH

We treat kratom and 7-OH dependence with buprenorphine-based MAT. Same-week appointments are available at our Chattanooga, Cleveland, Soddy-Daisy, and Ringgold locations, and most insurance plans cover treatment. Call 423-498-2000 or request a callback when you are ready.

Related reading

References

Primary legal and regulatory sources cited in this state-by-state tracker.

  1. U.S. Drug Enforcement Administration, Diversion Control Division. “Kratom (Mitragyna speciosa)” fact sheet, Drugs and Chemicals of Concern series (October 2025). [DEA]
  2. U.S. Food and Drug Administration. “FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers” (July 29, 2025). [FDA]
  3. U.S. Food and Drug Administration. “FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine” (July 15, 2025). [FDA]
  4. U.S. Drug Enforcement Administration. “Schedules of Controlled Substances: Temporary Placement of 7-Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I,” notice of intent, 91 FR 65370, FR Doc. 2026-20943, Docket No. DEA-1570 (October 14, 2026). [Federal Register]
  5. Code of Alabama. § 20-2-23 (Schedule I; mitragynine and 7-hydroxymitragynine). [State AG / Code]
  6. Indiana Code § 35-31.5-2-321 (synthetic drug, including mitragynine and 7-OH). [State Code]
  7. Louisiana Department of Revenue. “New Penalties for Kratom in Effect Aug. 1” (2025). [State]
  8. Louisiana Legislature. Senate Bill 154 (Act 41), 2025 Regular Session (enrolled). [LA Legislature]
  9. Wisconsin Statute 961.14 (Schedule I controlled substances). [State Code]
  10. Connecticut Department of Consumer Protection. “DCP Applauds Passage of Controlled Substance Drug Schedule Updates” (February 24, 2026). [State]
  11. Connecticut Department of Consumer Protection. “Kratom Update October 2025” (compliance window guidance). [State]
  12. General Laws of Rhode Island, Title 21, Chapter 21-28.12 — The Rhode Island Kratom Act (effective April 1, 2026). [State Code]
  13. Legislative Analysis and Public Policy Association. “Kratom: Summary of State Laws” (January 2026; research current as of January 2026). Baseline for every state on this page, updated with the laws enacted since. [LAPPA]
  14. Kansas Legislature. Senate Bill 430 (adds mitragynine to Schedule I; approved April 27, 2026) and House Bill 2365 (7-hydroxymitragynine; approved April 10, 2026). [SB 430] / [HB 2365]
  15. Maryland General Assembly. HB 1229, Public Health – Kratom Consumer Protection Act (2024, Chapter 748), and HB 1523 (2026, Chapter 354). [HB 1229] / [HB 1523]
  16. Utah Code § 4-45-104 (Kratom Consumer Protection Act: a kratom product must be registered with the Utah Department of Agriculture and Food before it is sold). [State Code]
  17. Tennessee General Assembly. HB1649 / SB1656 (“Matthew Davenport’s Law”), signed into law May 7, 2026 (Public Chapter 950). [LegiScan HB1649] / [LegiScan SB1656]
  18. Tennessee General Assembly. HB1647 (introduced version, replaced by HB1649). [LegiScan]
  19. WSMV4 News, Nashville. “Tennessee kratom ban bill heads to Gov. Bill Lee’s desk” (April 17, 2026). [News]
  20. Georgia General Assembly. HB181 (amended the 2019 KCPA, effective January 1, 2025), HB757 (a 2025 product-registration bill that never became law), HB968 (2026 ban proposal). [LegiScan HB181] / [LegiScan HB968]
  21. South Carolina Legislature. H.4636, H.4641, H.4648 (2026 session). [LegiScan H.4636]
  22. Washington State Legislature. SB 6287 (KCPA), SB 6196 (95% excise tax). [LegiScan SB 6287] / [LegiScan SB 6196]
  23. Centers for Disease Control and Prevention. “Increases in Kratom-Related Reports to Poison Centers — National Poison Data System, United States, 2015–2025.” MMWR 2026;75(11). [CDC MMWR]